Firefly Neuroscience (AIFF) Net Income towards Common Stockholders (2010 - 2026)

Firefly Neuroscience's Net Income towards Common Stockholders history runs 16 years deep, the most recent figure standing at -$2.1 million for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 87.92% year-over-year to -$2.1 million in Q1 2026; TTM through Mar 2026 was -$9.3 million, a 64.83% increase from a year earlier, with the FY2025 full-year figure at -$24.5 million, down 134.52% from the prior year.
• Net Income towards Common Stockholders climbed to -$2.1 million in Q1 2026 per AIFF's latest filing, from -$2.7 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $100615.0 in Q1 2023 and bottomed at -$17.3 million in Q1 2025.
• The 5-year median for Net Income towards Common Stockholders is -$2.4 million (2024), against an average of -$4.1 million.
• Across the five-year window, Net Income towards Common Stockholders plunged 4820.62% in 2022 and soared 104.84% in 2023, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$8.4 million in 2022, then surged by 101.2% to $100615.0 in 2023, then sank by 6734.2% to -$6.7 million in 2024, then jumped by 59.27% to -$2.7 million in 2025, then rose by 22.99% to -$2.1 million in 2026.
• Per Business Quant, the three latest AIFF Net Income towards Common Stockholders figures stand at -$2.1 million (Q1 2026), -$2.7 million (Q4 2025), and -$2.6 million (Q3 2025).